Biopolym. Cell. 2011; 27(3):214-220.
http://dx.doi.org/10.7124/bc.0000BC
Molecular Biomedicine
Study of the possible role of polymorphisms of the detoxication and coagulation system genes in pathogenesis of pregnancy loss
1Tatarskyy P. F., 1, 2Kucherenko A. M., 3Khazhilenko K. G., 3Zinchenko V. M., 4Ilyin I. E., 1Livshits L. A.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  2. Taras Shevchenko National University of Kyiv
    64/13, Volodymyrska Str., Kyiv, Ukraine, 01601
  3. "ISIDA" clinic
    65, Ivana Lepse Boulevard, Kyiv, Ukraine, 03126
  4. Reproductive Genetics Institute
    3d, Zoolohichna St, Kyiv, Ukraine, 03057

Abstract

Aim. To study association of polymorphisms of the genes of the first CYP1A1 (T6235C) and second GSTM1 («0»), GSTT1 («0»), GSTP1 (A313G) phases of detoxication system as well as polymorphic variants of the genes of proteins of coagulation system F2 (G20210A), F5 (G1691A), and folate metabolism system MTHFR (C677T) with pathogenesis of pregnancy loss. Methods. Polymorphic variants were analyzed using PCR followed by RFLP analysis in 86 healthy individuals and in 109 patients with different types of pregnancy loss. Results. Unfavorable polymorphic variants GSTP1 (313G) and CYP1A1 (6235C) were observed more frequently in the patients with pregnancy loss comparing to the control group. Conclusions. We assume that the 313G polymorphic variant of GSTP1 gene may be considered as a factor of hereditary susceptibility to pregnancy loss.
Keywords: pregnancy loss, detoxication system, blood coagulation system, DNA polymorphism
Full text: (PDF, in Ukrainian)

References

[1] Dubossarskaia Z. M., Duka Yu. M. Nevinoshuvannya vagitnosti Zdorov’ya Ukraine 2007 N 9 P. 62.
[2] Zhuk S. I., Kalinka J., Sidelcikova V. M. Nevynashivanie beremennosti: novyy vzglyad na staruyu problemu Zdorov’ya Ukraine 2007 N 5/1 P. 3–5.
[3] Ivashchenko T. E., Shved N. Iu., Kramareva N. A., Ailamazian E. K., Baranov V. S. Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis Genetika 2003 39, N 4 P. 525–529.
[4] Kolesnichenko LS, Kulinskii VI. Glutathione transferases. Usp Sovrem Biol. 1989; 107(2):179-94.
[5] Korsak V., Vassilyeva O., Isakova E., Kirsanov A. Oslozhneniya VRT/EKO Zhinochyi likar 2008 N 2 P. 10.
[6] Grishchenko V. I., Grishchenko M. G. Istoriya sozdaniya i razvitiya vspomogatel'nych reproduktivnych technologiy v Ukraine Meditsinskie aspekty zdorov'ya zhenshchiny 2008 N 4 (13) P. 91–94.
[7] Baranov V. S., Baranova E. V., Ivaschenko T. E., Aseev M. V. Human genome and «predisposition» genes (Introduction into predictive medicine) St. Petersburg: Intermedika, 2002 272 p.
[8] Raunio H., Pelkonen O. Cancer genetics: genetic factors in the activation and inactivation of chemical carcinogens Drugs, Diet and Disease. Mechanistic Approaches to Cancer / Eds C. Ioannides, D. F. V. Lewis New York: Ellis Horwood, 1995 Vol. l P. 229–258.
[9] Archakov A. I. Mikrosomal'noe okislenie St. Petersburg: Nauka, 1975 326 p.
[10] Koksal V., Baris I., Etlik O. Primer-engineered multiplex PCR– RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations Exp. Mol. Pathol 2007 83, N 1 P. 1–3.
[11] Lindqvist P. G., Zoller B., Dahlback B. Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden – an evolutionary advantage? Thromb. Haemost 2001 86, N 4 P. 1122–1123.
[12] Maniatis T., Fritsch E. F., Sambrook J. Molecular cloning: a laboratory manual New York: Cold Spring Harbor Lab. press, 1982 545 p.
[13] Wu M. T., Ho C. K., Huang S. L., Yeh Y. F., Liu C. L., Mao I. F., Christiani D. C. Modulating influence of cytochrome P-450 MspI polymorphism on serum liver function profiles in coke oven workers Occup. Environ. Med 1999 56, N 3:159– 163.
[14] Zusterzeel P. L., Nelen W. L., Roelofs H. M., Peters W. H., Blom H. J., Steegers E. A. Polymorphism in biotransformation enzymes and the risk for recurrent early pregnancy loss Mol. Hum. Reprod 2000 6, N 5:474–478.
[15] Livshyts H. B., Kravchenko S. A., Tatarskyi P. F., Sudoma I. A., Livshits L. A. Molecular-genetics analysis of natural and stimulated ovulation impairment Cytology and genetics 2008 42, N 2:63–69.
[16] Moore J. H. Computational analysis of gene-gene interactions using multifactor dimensionality reduction Expert Rev. Mol. Diagn 2004 4, N 6:795–803.
[17] Sullivan K. M., Dean A., Soe M. M. OpenEpi: a web-based epidemiologic and statistical calculator for public health Public Health Rep 2009 124, N 3:471–474.
[18] Hashimoto K., Shizusawa Y., Shimoya K., Ohashi K., Shimizu T., Azuma C., Murata Y. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion Hum. Reprod 1999 14, N 7 P. 1872–1874.
[19] Sottilotta G., Oriana V., Latella C., Luise F., Piromalli A., Ramirez F., Mamm C., Santoro R., Iannaccaro P., Muleo G., Lombardo V. T. Genetic prothrombotic risk factors in women with unexplained pregnancy loss Thromb. Res 2006 117, N 6 P. 681–684.
[20] Mitic G., Kovac M., Povazan L., Magic Z., Djordjevic V., Salatic I., Mitic I., Novakov-Mikic A. Inherited thrombophilia is associated with pregnancy losses that occur after 12th gestational week in Serbian population Clin. Appl. Thromb. Hemost 2010 16, N 4. P. 435–439.
[21] Sata F., Yamada H., Kondo T., Gong Y., Tozaki S., Kobashi G., Kato E. H., Fujimoto S., Kishi R. Glutathione S-transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss Mol. Hum. Reprod 2003 9, N 3 P. 165–169.
[22] Hirvonen A., Taylor J. A., Wilcox A., Berkowitz G., Schachter B., Chaparro C., Bell D. A. Xenobiotic metabolism genes and the risk of recurrent spontaneous abortion Epidemiology 1996 7, N 2 P. 206–208.
[23] Zhao Y., Marotta M., Eichler E. E., Eng C., Tanaka H. Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes PLoS Genet 2009 5, N 5 e1000472.
[24] Frova C. Glutathione transferases in the genomics era: new insights and perspectives Biomol Eng 2006 23, N 4 P. 149–169.
[25] Kargas C., Krupa R., Walter Z. Combined genotype analysis of GSTM1 and GSTT1 polymorphisms in a Polish population Hum. Biol 2003 75, N 2 P. 301–307.
[26] Kempkes M., Golka K., Reich S., Reckwitz T., Bolt H. M. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder Arch. Toxicol 1996 71, N 1–2 P. 123–126.
[27] Dimitriadis E., White C. A., Jones R. L., Salamonsen L. A. Cytokines, chemokines and growth factors in endometrium related to implantation Hum. Reprod. Update 2005 11, N 6 P. 613–630.
[28] Lindenberg S. Experimental studies on the initial trophoblast endometrial interaction Dan. Med. Bull 1991 38, N 5 P. 371–380.
[29] Williams T. J., Peck M. J. Role of prostaglandin-mediated vasodilatation in inflammation Nature 1977 270, N 5637 P. 530–532.
[30] Giles H., Leff P., Bolofo M. L., Kelly M. G., Robertson A. D. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist Br. J. Pharmacol 1989 96, N 2 P. 291–300.
[31] Murakami M., Kudo I. Diversity and regulatory functions of mammalian secretory phospholipase A2s Adv. Immunol 2001 77 P. 163–194.
[32] Miyazaki T., Sueoka K., Dharmarajan A. M., Atlas S. J., Bulkley G. B., Wallach E. E. Effect of inhibition of oxygen free radical on ovulation and progesterone production by the in-vitro perfused rabbit ovary J. Reprod. Fertil 1991 91, N 1 P. 207– 212.
[33] Koga T., Kuwahara I., Lillehoj E. P., Lu W., Miyata T., Isohama Y., Kim K. C. TNF-alpha induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implication Am. J. Physiol. Lung Cell Mol. Physiol 2007 293, N 3 P. L693–701.
[34] Meseguer M., Aplin J. D., Caballero-Campo P., O'Connor J. E., Martin J. C., Remohi J., Pellicer A., Simon C. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst Biol. Reprod 2001 64, N 2 P. 590–601.
[35] Fialova L., Malbohan I., Kalousova M., Soukupova J., Krofta L., Stipek S., Zima T. Oxidative stress and inflammation in pregnancy Scand. J. Clin. Lab. Invest 2006 66, N 2 P. 121– 127.
[36] Cadden K. A., Walsh S. W. Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia Hypertens Pregnancy 2008 27, N 4 P. 396–405.